Vontobel Holding
NVO

Vontobel Holding’s Novo Nordisk NVO Stock Holding History

Vontobel Holding’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.19M Buy
+87,500
New +$3.76M 0.01% 485
2026
Q1 		– Sell
-119,000
Closed -$6.05M – 1403
2025
Q4 		$6.05M Buy
119,000
+12,400
+12% +$634K 0.02% 354
2025
Q3 		$5.92M Buy
106,600
+14,600
+16% +$855K 0.02% 350
2025
Q2 		$6.35M Buy
+92,000
New +$6.26M 0.02% 327

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Vontobel Holding's NVO Position: Q2 2026 in Review

Vontobel Holding reduced its Novo Nordisk (NVO) stake by 61% in Q2 2026, selling an estimated $7.57M and leaving 113,956 shares worth $5.46M. The position accounts for 0.02% of the portfolio, ranked #435.

Vontobel Holding first reported a position in NVO in Q2 2022 and has held it in 12 quarters since. The position peaked at $22.6M in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Vontobel Holding held 113,956 shares of Novo Nordisk worth $5.46M as of Q2 2026.
  • Vontobel Holding sold 176,266 Novo Nordisk shares in Q2 2026, an estimated $7.57M.
  • Novo Nordisk made up 0.02% of Vontobel Holding's portfolio in Q2 2026, its #435 holding.
  • Vontobel Holding first reported a position in Novo Nordisk in Q2 2022 and has held it in 12 quarters since.
  • Vontobel Holding's Novo Nordisk position peaked at $22.6M in Q4 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.